To Identify Suspect in Idaho Killings, F.B.I. Used Restricted Consumer DNA Data
By Mike Baker,
The New York Times
| 02. 25. 2025
As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students in the fall of 2022, they were focused on a key piece of evidence: DNA on a knife sheath that was found at the scene of the crime.
At first they tried checking the DNA with law enforcement databases, but that did not provide a hit. They turned next to the more expansive DNA profiles available in some consumer databases in which users had consented to law enforcement possibly using their information, but that also did not lead to answers.
F.B.I. investigators then went a step further, according to newly released testimony, comparing the DNA profile from the knife sheath with two databases that law enforcement officials are not supposed to tap: GEDmatch and MyHeritage.
It was a decision that appears to have violated key parameters of a Justice Department policy that calls for investigators to operate only in DNA databases “that provide explicit notice to their service users and the public that law enforcement may use their service sites.”...
Related Articles
By Emily Baumgaertner Nunn, The New York Times | 09.08.2026
It is one of biology’s most ingenious rhythms: Every baby is born young. No matter how much wear and tear their parents’ DNA accumulated over their lifetimes, reproduction erases the molecular scars, handing a clean slate to the next generation...
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...